Zhiqiang Chen

Zhiqiang Chen has a diverse work experience in biologics CMC and protein science. Zhiqiang currently serves as the Executive Director and Head of Biologics CMC at D3 Bio since 2021. Prior to this, they were the Director and Senior Director of CMC and Protein Science at Adagene from 2018 to 2021. During this period, they were responsible for overseeing all CMC activities from preclinical development through clinical supplies for global clinical and registration studies. Zhiqiang also managed CDMOs to ensure timely execution of CMC activities. From 2014 to 2018, they were a Scientist I&II at Bristol-Myers Squibb, where they worked on biologics process development, and published several papers and patents related to protein purification and design of therapeutic IgG4.

Zhiqiang Chen holds a Bachelor of Engineering (BEng) in pharmaceutical engineering from Tianjin University and a Doctor of Philosophy (PhD) in Chemical and Materials Science Engineering from the University of Kentucky.